尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Severino Michael, Vice-Président. Insider active across 4 companies, notably AbbVie Inc.. In total, 13 filings have been logged. History available since 27 December 2021. The latest transaction was disclosed on 6 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
SEVERINO MICHAEL is Vice-Président. He is associated with AbbVie Inc., Avantor, Inc., Sarepta Therapeutics, Inc. and Viatris Inc. The 13 filings on record cover the period from 2021-12-30 to 2026-07-29 in the recent sample, with transaction nature Attribution; the aggregated buy and sell amounts are 0 and 0 in this sample. Recent filings include amounts of 5192419.66556284, 4958931.849465492, 4166254.209149305 and 3838217.864609483 for AbbVie Inc., as well as 0 for Viatris Inc., and one record with no amount indicated for Sarepta Therapeutics, Inc.